| # | Drug | Count |
|---|---|---|
| 0 | TREPROSTINIL | 4511 |
| 1 | AMBRISENTAN | 3364 |
| 2 | SILDENAFIL CITRATE | 3330 |
| 3 | MACITENTAN | 3310 |
| 4 | TADALAFIL | 2897 |
| 5 | BOSENTAN | 2297 |
| 6 | SILDENAFIL | 2012 |
| 7 | SELEXIPAG | 1718 |
| 8 | FUROSEMIDE | 1699 |
| 9 | SILDENAFIL POWDER, | 1445 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPOPROSTENOL | 1105 | 0.0843 |
| 1 | SELEXIPAG | 1718 | 0.0658 |
| 2 | MACITENTAN | 3310 | 0.0474 |
| 3 | BOSENTAN | 2297 | 0.0456 |
| 4 | SILDENAFIL POWDER, | 1445 | 0.0403 |
| 5 | TREPROSTINIL | 4511 | 0.0353 |
| 6 | RIOCIGUAT | 1130 | 0.0344 |
| 7 | TADALAFIL | 2897 | 0.0287 |
| 8 | AMBRISENTAN | 3364 | 0.0269 |
| 9 | SILDENAFIL CITRATE | 3330 | 0.0261 |
| # | Drug class | Count |
|---|---|---|
| 0 | Endothelin Receptor Antagonist [EPC] | 6558 |
| 1 | Prostacycline Vasodilator [EPC] | 5440 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 4240 |
| 3 | Loop Diuretic [EPC] | 2152 |
| 4 | Prostacyclin Receptor Agonist [EPC] | 1718 |
| 5 | Soluble Guanylate Cyclase Stimulator [EPC] | 1130 |
| 6 | Aldosterone Antagonist [EPC] | 1086 |
| 7 | Factor Xa Inhibitor [EPC] | 949 |
| 8 | Corticosteroid [EPC] | 935 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 900 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacyclin Receptor Agonist [EPC] | 1718 | 0.0658 |
| 1 | Prostacycline [EPC] | 59 | 0.0632 |
| 2 | Prostacycline Vasodilator [EPC] | 5440 | 0.0395 |
| 3 | Soluble Guanylate Cyclase Stimulator [EPC] | 1130 | 0.0334 |
| 4 | Endothelin Receptor Antagonist [EPC] | 6558 | 0.0327 |
| 5 | Phosphodiesterase 5 Inhibitor [EPC] | 4240 | 0.0313 |
| 6 | Lead Chelator [EPC] | 2 | 0.0238 |
| 7 | Interleukin-5 Antagonist [EPC] | 12 | 0.0174 |
| 8 | Provitamin D2 Compound [EPC] | 345 | 0.0116 |
| 9 | Vasopressin V2 Receptor Antagonist [EPC] | 130 | 0.0087 |